[{"Assets_0_Q2_USD":12221686000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":261468000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":261020000.0,"StockholdersEquity_0_Q2_USD":9196396000.0,"RevenuesConverted_2_Q2_USD":3517675000.0,"RevenuesConverted_1_Q2_USD":1793370000.0,"NetIncomeLossConverted_2_Q2_USD":720062000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":258988000.0,"NetIncomeLossConverted_1_Q2_USD":66924000.0,"EarningsPerShareDiluted_2_Q2_USD":2.75,"EarningsPerShareDiluted_1_Q2_USD":0.26,"EarningsPerShareBasic_2_Q2_USD":2.78,"EarningsPerShareBasic_1_Q2_USD":0.26,"CommonStockSharesOutstanding_0_Q2_shares":259114000.0,"CommonStockSharesConverted_0_Q2_shares":259114000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":721288000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":259179000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20210730"}]